CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
P/E Ratio HistoryFair Value
Percentile Rank8
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-33.83
↓ 22% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive declineFair Value
Average
-27.64
Historical baseline
PeriodValueYoY Change
2025-33.83-1339.7%
20242.73+101.4%
2023-201.06-18884.5%
2022-1.06+55.8%
2021-2.40+48.6%
2020-4.66-26.5%
2019-3.68+50.4%
2018-7.44+59.2%
2017-18.20-169.3%
2016-6.76-